Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs

E-ISSN： 1873-4286|18|24|3467-3479

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.24, 2012-08, pp. : 3467-3479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 292-308

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 803-820

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Histone Deacetylase as New Anticancer Agents

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1505-1511

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

By Marks Paul A

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1049-1066

Informa Healthcare

Access to resources Recommend Favorite

Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 337-351

Bentham Science Publishers

Access to resources Recommend Favorite